Viewing Study NCT04431258


Ignite Creation Date: 2025-12-25 @ 12:06 AM
Ignite Modification Date: 2026-02-20 @ 3:44 AM
Study NCT ID: NCT04431258
Status: COMPLETED
Last Update Posted: 2024-03-18
First Post: 2020-05-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study
Sponsor: Ability Pharmaceuticals SL
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module